(Q39846677)

15 September 2017

title

Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer (English)

1 reference

10.1002/1097-0142(197802)41:2<387::AID-CNCR2820410201>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C387::AID-CNCR2820410201%3E3.0.CO;2-X

10.1002/1097-0142(197802)41:2<387::AID-CNCR2820410201>3.0.CO;2-X

15 December 2022

main subject

phase II clinical trial

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C387::AID-CNCR2820410201%3E3.0.CO;2-X

15 December 2022

1 reference

R. G. Wiggans

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A147131

15 December 2022

P. V. Woolley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A147131

15 December 2022

J. S. Macdonald

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A147131

15 December 2022

T. Smythe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A147131

15 December 2022

W. Ueno

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A147131

15 December 2022

P. S. Schein

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A147131

15 December 2022

language of work or name

English

0 references

publication date

1 February 1978

1 reference

full work available at URL

15 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197802)41:2%3C387::AID-CNCR2820410201%3E3.0.CO;2-X

1 reference

10.1002/1097-0142(197802)41:2<387::AID-CNCR2820410201>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C387::AID-CNCR2820410201%3E3.0.CO;2-X

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197802)41:2%3C387::AID-CNCR2820410201%3E3.0.CO;2-X

15 December 2022

1 reference

10.1002/1097-0142(197802)41:2<387::AID-CNCR2820410201>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C387::AID-CNCR2820410201%3E3.0.CO;2-X

15 December 2022

1 reference

15 September 2017

volume

41

1 reference

15 September 2017

issue

2

1 reference

15 September 2017

page(s)

387-391

1 reference

The integration of chemotherapy into a combined modality approach for cancer treatment. VI. Pancreatic adenocarcinoma

15 September 2017

cites work

3

1 reference

10.1002/1097-0142(197802)41:2<387::AID-CNCR2820410201>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C387::AID-CNCR2820410201%3E3.0.CO;2-X

Streptozotocin therapy in 22 cancer patients

15 December 2022

4

1 reference

10.1002/1097-0142(197802)41:2<387::AID-CNCR2820410201>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C387::AID-CNCR2820410201%3E3.0.CO;2-X

Proceedings: A controlled study of combined 1,3-bis-(2-chloroethyl)-1-nitrosourea and 5-fluorouracil therapy for advanced gastric and pancreatic cancer

15 December 2022

5

1 reference

10.1002/1097-0142(197802)41:2<387::AID-CNCR2820410201>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C387::AID-CNCR2820410201%3E3.0.CO;2-X

Renal toxicity in man treated with mitomycin C

15 December 2022

6

1 reference

10.1002/1097-0142(197802)41:2<387::AID-CNCR2820410201>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C387::AID-CNCR2820410201%3E3.0.CO;2-X

Chemotherapy in pancreatic carcinoma: 5 fluorouracil (5FU) and 1,3 bis-(2 chloretjyl)-1-nitrosourea (BCNU)

15 December 2022

7

1 reference

10.1002/1097-0142(197802)41:2<387::AID-CNCR2820410201>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C387::AID-CNCR2820410201%3E3.0.CO;2-X

15 December 2022

Cancer Treatment Reports

8

60

1597

Macdonald

1976

1 reference

10.1002/1097-0142(197802)41:2<387::AID-CNCR2820410201>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C387::AID-CNCR2820410201%3E3.0.CO;2-X

Current diagnosis and management of pancreatic carcinoma

15 December 2022

9

1 reference

10.1002/1097-0142(197802)41:2<387::AID-CNCR2820410201>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C387::AID-CNCR2820410201%3E3.0.CO;2-X

Mitomycin-C in the therapy of far-advanced malignant tumors

15 December 2022

10

1 reference

10.1002/1097-0142(197802)41:2<387::AID-CNCR2820410201>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C387::AID-CNCR2820410201%3E3.0.CO;2-X

Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer

15 December 2022

12

1 reference

10.1002/1097-0142(197802)41:2<387::AID-CNCR2820410201>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C387::AID-CNCR2820410201%3E3.0.CO;2-X

15 December 2022

Cancer Treatment Reports

13

60

1659

Moertel

1976

1 reference

10.1002/1097-0142(197802)41:2<387::AID-CNCR2820410201>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C387::AID-CNCR2820410201%3E3.0.CO;2-X

Clinical antitumor activity and toxicity of streptozotocin (NSC-85998)

15 December 2022

17

1 reference

10.1002/1097-0142(197802)41:2<387::AID-CNCR2820410201>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197802)41:2%3C387::AID-CNCR2820410201%3E3.0.CO;2-X

15 December 2022

Identifiers

10.1002/1097-0142(197802)41:2<387::AID-CNCR2820410201>3.0.CO;2-X

1 reference

15 September 2017

1 reference